Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With Small Cell Lung Cancer

NCT05158491 is registered in ClinicalTrials.gov with JenKem Technology Co., Ltd. as lead sponsor.

NCT NCT05158491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With Small Cell Lung Cancer
Lead sponsor
JenKem Technology Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 11, 2021
Completion date
March 31, 2023
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer (sclc)